This was notably superior to standard first-line therapies, which included prednisone, intravenous immunoglobulin (IVIG), or ...

CONCORD – With some elective surgeries now being cancelled and delayed in New Hampshire due to a national shortage of ...

Dr. Marla Lipsyc-Sharf reviews her recent session at the 2024 SABCS meeting, discussing biopsy approaches and treatment ...

Osmotic Pumps Market. The global osmotic pumps market is set for substantial growth, with revenue projected to rise from USD ...

"Medical Journeys" chart a path each step of the way for physicians and patients and provide continual resources and support, ...

Elizabeth A. Brem, MD, an assistant clinical professor in the Division of Hematology/Oncology, School of Medicine at the University of California, Irvine, discusses multiple types of therapies used in ...

Attorney General Kris Mayes took the first steps Friday to putting convicted murderer Aaron Gunches to death. Mayes asked the ...

Roche’s Lunsumio may be the first CD20xCD3 T-cell engager approved by the FDA, but intravenous administration puts the drug ...

It is a serious mistake for Arizona to restart the machinery of death and for other states to cling to capital punishment.

It is a serious mistake for Arizona to restart the machinery of death and for other states to cling to capital punishment.

Merck's ovarian cancer trial met its primary endpoint, while lymphoma trial data set the Phase 3 dose for zilovertamab ...